You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - etiology, pathogenesis and animal models
FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Di Paolo J, Blomgren P, Dolton M, et al
FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis
Annals of the Rheumatic Diseases 2016;75:443-444.